Wordt geladen...
FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells
Cancer initiating cells (CICs) drive tumor formation and drug-resistance, but how they develop drug-resistance characteristics is not well understood. In this study, we demonstrate that chemotherapeutic agent FOLFOX, commonly used for drug-resistant/metastatic colorectal cancer (CRC) treatment, indu...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7828641/ https://ncbi.nlm.nih.gov/pubmed/33451103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22020753 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|